Viromed Medical AG / Key word(s): Takeover/Mergers & Acquisitions Viromed Medical AG completes acquisition of pharmedix GmbH 20-Dec-2024 / 14:05 CET/CEST Disclosure of an inside
Original-Research: Cantourage Group SE – from NuWays AG 20.12.2024 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group.The
Issuer: Mainz BioMed N.V. / Key word(s): Alliance 19.12.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed
EQS-News: iOmx Therapeutics AG / Key word(s): Study iOmx Therapeutics submits Clinical Trial Application for IOMX-0675 19.12.2024 / 14:00 CET/CEST The issuer is solely responsible
EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision/AGM/EGM Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division 19.12.2024 / 12:39 CET/CEST
EQS Newswire / 19/12/2024 / 15:57 UTC+8 A new nanodrug development company – MegaPro Biomedical Co., Ltd. (hereinafter referred to as “MegaPro”,
EQS-News: Cantourage Group SE / Key word(s): Expansion Cantourage Group SE exports medical craft cannabis for the first time to the growth market of Poland;
EQS-News: Douglas AG / Key word(s): Annual Results/Annual Report DOUGLAS Group achieves strong results and strategic progress in financial year 2023/24 19.12.2024 / 07:30 CET/CEST
Xlife Sciences AG / Key word(s): ESG Xlife Sciences AG Publishes 2023 ESG Report: A Continued Commitment to Sustainable Innovation 19.12.2024 / 07:00 CET/CEST Zurich,
Original-Research: MPH Health Care AG – from First Berlin Equity Research GmbH 18.12.2024 / 15:36 CET/CESTDissemination of a Research, transmitted by EQS News – a